Sculptra vs polynucleotides UK, what is the difference?
If you are noticing facial volume loss, looser skin, or under eye hollowing and crepey texture, you may be considering injectable treatments that improve the skin gradually. Two popular options in UK clinics are Sculptra and polynucleotides.
They are often grouped together as biostimulators, but they work in different ways and suit different concerns. This guide explains how each treatment works, what you can realistically expect, how long results last, typical treatment courses, risks, and whether they can be combined.
What are biostimulators, and how are they different from HA fillers?
Biostimulators are injectable treatments designed to encourage your skin to repair and rebuild over time, typically by stimulating collagen and supporting tissue quality. They are usually chosen when patients want gradual, natural looking change, rather than immediate filling.
Hyaluronic acid (HA) fillers are gels that usually provide instant volume and contour. They can be adjusted and, in many cases, are reversible with hyaluronidase.
Biostimulators:
– Tend to work gradually over weeks to months
– Aim to improve skin structure and firmness, sometimes with subtle volume restoration
– Are usually not immediately reversible
Neither approach is universally better. The best option depends on whether your main issue is structural volume loss, skin quality, fine lines, laxity, or a mix.
What Sculptra does
### What is Sculptra?
Sculptra is an injectable made from poly L lactic acid (PLLA). It is classed as a collagen stimulator. After treatment, your body gradually responds by producing new collagen, which can help restore structure and support in areas affected by age related volume loss.
How Sculptra works
Sculptra is typically diluted and placed in the deeper tissue planes. The initial fullness you may see straight after treatment is mostly from the fluid used to reconstitute the product. The main effect develops as collagen builds over time.
What it is best at:
– Gradual restoration of volume and support
– Improving the look of facial hollowing and softening shadows
– Supporting mild to moderate skin laxity, especially when laxity is linked to volume loss
Best indications for Sculptra
Sculptra is commonly considered for:
– Mid face volume loss (cheeks)
– Temples
– Preauricular area (in front of the ears) to support lower face laxity
– Jawline support in selected patients
It is usually not the first choice for very superficial fine lines or for the thin under eye skin, where product placement risks are higher and a different approach is often preferred.
Typical course and timeline
Protocols vary by patient and clinician, but a common plan is:
– 2 to 3 sessions, spaced around 4 to 8 weeks apart
– Results begin to show gradually from around 6 to 12 weeks
– Full effect is often judged at around 3 to 6 months
You may be advised to massage the treated areas after your appointment, depending on the technique used. Your clinician should provide specific aftercare instructions.
Longevity
Sculptra results are often described as long lasting for a collagen stimulating injectable. Many patients can see benefits for up to 2 years or longer, but longevity varies with:
– Baseline collagen and skin quality
– Degree of volume loss
– Age and lifestyle factors
– Product amount and treatment plan
Maintenance treatments may be suggested depending on your response.
What polynucleotides do
### What are polynucleotides?
Polynucleotides are injectable skin revitalising products derived from purified DNA fragments. They are used to support skin regeneration, improve hydration, and strengthen the skin barrier. In aesthetics, they are often chosen when the main goal is skin quality, rather than adding volume.
How polynucleotides work
Polynucleotides are thought to support tissue repair processes by:
– Improving the skin environment for fibroblasts, the cells involved in collagen and elastin production
– Supporting hydration and skin elasticity
– Reducing the appearance of fine crepiness and improving skin texture over time
Different brands and formulations exist, and clinical outcomes can vary depending on the product, injection depth, and patient factors.
Best indications for polynucleotides
Polynucleotides are commonly considered for:
– Under eye rejuvenation, especially crepey texture and early laxity
– Fine lines and textural concerns on the cheeks
– Redness prone or sensitised looking skin, where improving overall skin quality is a goal
РNeck and d̩colletage skin quality concerns
Polynucleotides are not designed to replace the kind of lift or projection that a filler, or a collagen volumiser like Sculptra, can provide.
Typical course and timeline
A common approach is:
– 2 to 4 sessions, spaced around 2 to 4 weeks apart
– Early improvements in hydration or glow may be noticed within 2 to 4 weeks
– Texture and firmness changes are usually more gradual and assessed over 6 to 12 weeks
Because under eye skin is thin and reactive, treatment should be conservative and tailored.
Longevity
Skin quality improvements may last for several months, often around 6 to 9 months, though this varies. Many patients choose maintenance treatments to keep the skin supported, particularly in the under eye area.
Sculptra vs polynucleotides UK, side by side comparison
| Feature | Sculptra (PLLA) | Polynucleotides |
|---|---|---|
| Best for | Volume loss, structural support, mild to moderate laxity linked to volume loss | Skin quality, hydration, fine crepiness, under eye texture and early laxity |
| Results speed | Gradual, typically weeks to months | Often earlier skin hydration changes, texture improves over weeks |
| Typical course | 2 to 3 sessions, 4 to 8 weeks apart | 2 to 4 sessions, 2 to 4 weeks apart |
| Longevity | Often up to around 2 years, varies | Often several months, commonly 6 to 9 months, varies |
| Downtime | Usually minimal, bruising and swelling possible | Usually minimal, small bumps and bruising possible |
| Reversibility | Not immediately reversible | Not immediately reversible |
| Key risks | Bruising, swelling, tenderness, nodules, unevenness, vascular risks with any injection | Bruising, swelling, small lumps, inflammatory reactions, vascular risks with any injection |
| Under eye suitability | Usually not first line, higher risk area | Often used for under eyes in suitable patients |
Which is best for volume loss, skin laxity, and under eye rejuvenation?
### Volume loss
If your main concern is flattening of the cheeks, hollowing at the temples, or general loss of facial support, Sculptra is often the more appropriate biostimulator. It is designed to rebuild collagen in a way that can restore structure, not just surface skin quality.
Polynucleotides may still be useful alongside, but they are less likely to address deeper volume loss on their own.
Skin laxity
Skin laxity can have multiple causes, including collagen loss, elastin changes, and loss of fat support. In practice:
– Sculptra may help when laxity is related to loss of underlying support
– Polynucleotides may help when laxity is mild and the goal is to improve skin texture and resilience
For significant laxity, patients may need to discuss other options, including energy based treatments or surgery, depending on suitability.
Under eye rejuvenation
Under eyes are complex. Dark circles can be caused by shadowing from hollows, pigmentation, visible blood vessels, thin skin, or fluid retention.
Polynucleotides are often chosen for:
– Crepey under eye skin
– Fine lines and early laxity
– Improving skin quality where filler would be unsuitable
Sculptra is generally used with caution around the under eye area and is not usually a first choice there. If your main issue is true under eye hollowing, HA filler, surgical assessment, or other targeted treatments may be more appropriate, depending on anatomy.
Can you combine Sculptra and polynucleotides?
In selected patients, yes. Combination treatment can make sense because they target different layers and different goals.
A sample layering plan
This is an example of how a clinician might structure treatment, but it must be personalised:
– Stage 1: Address foundational support and volume loss with Sculptra in areas such as the mid face and temples, over 2 to 3 sessions
– Stage 2: Once the face is more supported, focus on delicate skin quality areas, such as under eyes, with polynucleotides over 2 to 4 sessions
– Maintenance: Review at 6 to 12 months to decide whether to repeat polynucleotides, and at 18 to 24 months for Sculptra maintenance, if needed
Some clinicians may alternate treatments rather than completing one fully first. Timing depends on your response, healing, and the injection sites.
Who should avoid or seek medical review first
You should disclose your full medical history and seek a medical assessment if you:
– Are pregnant or breastfeeding
– Have a history of severe allergies or anaphylaxis
– Have autoimmune or inflammatory conditions, especially if not well controlled
– Are immunosuppressed or undergoing cancer treatment, unless cleared by your specialist
– Have active skin infection, cold sores in the area, or significant dermatitis
– Have a tendency to form hypertrophic scars or keloids, or a history of problematic lumps after injectables
– Have had recent dental infection or procedures, or planned dental work, depending on treatment area
If you have had previous filler complications, including vascular occlusion or persistent swelling, this should be discussed before any biostimulator treatment.
Safety, expectations, and budgeting
Both treatments are generally well tolerated when performed by trained medical professionals, but no injectable is risk free.
Practical points to consider:
– Results are gradual, especially with Sculptra, so you need to be comfortable waiting for improvement
– Under eyes need conservative treatment, and not all under eye concerns are injectable problems
– You may need more than one session, so ask for a plan that includes likely number of sessions and review points
– Choose a clinician who can explain anatomy, realistic outcomes, and the clinic approach to managing complications
Choosing the right option
As a simple guide:
– Choose Sculptra if your main concern is volume loss and structural support, and you want gradual, longer term collagen based improvement
– Choose polynucleotides if your main concern is skin quality, especially under eyes, fine crepiness, and hydration
– Consider a combination approach if you have both deeper volume loss and superficial skin quality issues
A face to face assessment is the safest way to decide which treatment, or combination, fits your anatomy, timelines, and budget. Patients can be assessed by experienced medical professionals at Renovatio Clinic, and an individualised plan can be discussed with a focus on safe, realistic outcomes.
